These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16776237)

  • 21. [Differential diagnosis and therapy of primary hyperaldosteronism].
    Gärtner F; Grotz W; Schollmeyer P
    Dtsch Med Wochenschr; 1998 Jul; 123(28-29):873-6. PubMed ID: 9693658
    [No Abstract]   [Full Text] [Related]  

  • 22. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
    Mahmud A; Mahgoub M; Hall M; Feely J
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Biosynthesis of aldosterone and 11-desoxycorticosterone in the adrenal gland and in adenoma in a patient with primary hyperaldosteronism].
    Dahm K; Breuer H; Bayer JM
    Acta Endocrinol (Copenh); 1969 Nov; 62(3):425-37. PubMed ID: 5395008
    [No Abstract]   [Full Text] [Related]  

  • 24. [A case of inactive adrenal node that transformed to adenoma with manifestations of primary hyperaldosteronism in a patient with essential hypertension].
    Hatzitolios A; Delivoria C; Karabatsu S; Savopoulos C; Karamuzia M; Tsatidis R; Tataridis A; Kartavenko IM
    Klin Med (Mosk); 2004; 82(9):67-8. PubMed ID: 15540428
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical characteristics of primary and secondary aldosteronism].
    Nishikawa T; Saito J
    Nihon Rinsho; 2006 May; Suppl 1():621-3. PubMed ID: 16776232
    [No Abstract]   [Full Text] [Related]  

  • 26. Benign desoxycorticosterone-producing adrenal tumor.
    Kondo K; Saruta T; Saito I; Yoshida R; Maruyama H; Matsuki S
    JAMA; 1976 Aug; 236(9):1042-4. PubMed ID: 989580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical management of aldosterone-producing adenomas.
    Ferriss JB
    Ann Intern Med; 2000 Apr; 132(7):593-4; author reply 594. PubMed ID: 10744603
    [No Abstract]   [Full Text] [Related]  

  • 28. [Endocrine diseases with hypertension].
    Katayama S
    Nihon Rinsho; 2006 Sep; Suppl 3():499-503. PubMed ID: 17022597
    [No Abstract]   [Full Text] [Related]  

  • 29. [Myelolipoma].
    Tamura N; Nakao K
    Nihon Rinsho; 2006 May; Suppl 1():747-9. PubMed ID: 16776265
    [No Abstract]   [Full Text] [Related]  

  • 30. Primary aldosteronism: the most frequent form of secondary hypertension?
    Shargorodsky M; Zimlichman R
    Isr Med Assoc J; 2002 Jan; 4(1):32-3. PubMed ID: 11802308
    [No Abstract]   [Full Text] [Related]  

  • 31. [Investigation of hyperaldosteronism in the hypertensive patient. Why? When? How?].
    Herpin D; Sosner P; Amar J; Chamontin B
    Arch Mal Coeur Vaiss; 2003 Jan; 96(1):37-42. PubMed ID: 12613148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adrenal gland: Cancer target of mitotane identified.
    Holmes D
    Nat Rev Endocrinol; 2015 Nov; 11(11):631. PubMed ID: 26370730
    [No Abstract]   [Full Text] [Related]  

  • 33. [Familial pheochromocytoma].
    Tamura N; Nakao K
    Nihon Rinsho; 2006 May; Suppl 1():730-4. PubMed ID: 16776261
    [No Abstract]   [Full Text] [Related]  

  • 34. Electron microscopic findings in benign deoxycorticosterone and 11-deoxycortisol-producing adrenal tumor.
    Osanai T; Konta A; Chui D; Kanazawa T; Onodera K; Kogawa T
    Arch Pathol Lab Med; 1990 Aug; 114(8):829-31. PubMed ID: 2375656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hypertension secondary to pheochromocytoma].
    Miyajima E
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():536-9. PubMed ID: 15171431
    [No Abstract]   [Full Text] [Related]  

  • 36. Spironolactone management of resistant hypertension.
    Marrs JC
    Ann Pharmacother; 2010 Nov; 44(11):1762-9. PubMed ID: 20978214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A young woman with a severe bilateral pneumonia as the presenting sign of an adrenal carcinoma.
    Chamuleau SA; Corssmit EP; Pereira AM; van de Berg BT; Siegert CE
    Neth J Med; 2008 Mar; 66(3):121-4. PubMed ID: 18349468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnosis and therapy of primary hyperaldosteronism].
    Hodler J
    Schweiz Med Wochenschr; 1972 Jul; 102(30):1039-44. PubMed ID: 4572955
    [No Abstract]   [Full Text] [Related]  

  • 39. Aldosterone antagonists: effective add-on therapy for the treatment of resistant hypertension.
    Gaddam KK; Pratt-Ubunama MN; Calhoun DA
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):353-9. PubMed ID: 16716096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
    Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M
    J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.